Back to search

Article

Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment

2024-09-10

Abstract excerpt

<h4>Background</h4> Treatment with immunotherapy can elicit varying responses across cancer types, and the mechanistic underpinnings that contribute to response vs. progression remain poorly understood. However, to date there are few preclinical models that accurately represent these disparate disease scenarios. <h4>Methods</h4> Using combinatorial radio-immunotherapy consisting of PD-1 blockade, IL2Rβγ biased s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ed07fc7a-3876-59a8-bcb9-678b3947fbe1
DOI
10.1101/2024.09.06.611679
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironmentDOI 10.1101/2024.09.06.611679
Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activitySemantic proximity
Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancerSemantic proximity
Spatial Biology and Organoid Technologies Reveal a Potential Therapy-Resistant Cancer Stem Cell Population in Pancreatic Ductal AdenocarcinomaSemantic proximity
Context-specific GITR agonism potentiates anti-PD-L1 and CD40-based immuno-chemotherapy combination in heterogeneous pancreatic tumorsSemantic proximity
Immune and stromal features of durable complete response to radiation and dual immune checkpoint blockade in pancreatic cancerSemantic proximity
Advances in cancer immunotherapy: historical perspectives, current developments, and future directionsSemantic proximity
Tumor-specific CD4 T cells cooperate with myeloid cells to remodel the pancreatic tumor microenvironment and enable effective immunotherapySemantic proximity
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC ModelSemantic proximity
Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCCSemantic proximity
Targeting tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockadeSemantic proximity
Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and MetastasisSemantic proximity
OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumSemantic proximity
Select a neighboring publication to make it the new centre.